Headlands Research Acquires AMCR Institute


Headlands Research has announced the acquisition of AMCR Institute, which has been in operation for more than 20 years. The site’s team brings experience in metabolic, endocrine, and medical device research to the growing clinical research site network.

Led by principal investigator (PI) Timothy S. Bailey, MD, FACE, FACP, CPR, the San Diego–based clinical research site specializes in metabolic, endocrine, and other chronic conditions such as type 1 and type 2 diabetes and obesity. Bailey is a board-certified endocrinologist and is certified by the Association of Clinical Research Professionals (ACRP). He and his staff have worked with thousands of volunteers in Phase I-IV trials and have extensive experience with the evaluation of medical devices such as continuous glucose monitors (CGMs).

The acquisition of AMCR Institute, now known as Headlands Research AMCR Institute, is the most recent as the company expands its clinical research site network to support more clinical trials and provide access to investigational therapies to a diverse, representative population. Headlands Research recently launched one new clinical research site and acquired two additional established sites: Headlands Research Detroit serves multiple therapeutic areas, including Alzheimer’s disease and vaccines; Headlands Research Eastern Massachusetts specializes in neurodegenerative diseases such as Alzheimer’s disease, and Clinvest Research specializes in chronic diseases including migraine and arthritis.


Headlands Research Acquires AMCR Institute, Adding Medical Device Expertise to the Clinical Research Site Network. (2023, July 27). Business Wire.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.